Firefly Neuroscience, Inc.
AIFF
$1.08
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 71.91% | 1,027.91% | 677.36% | 1,075.76% | 2,890.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 71.91% | 1,027.91% | 677.36% | 1,075.76% | 2,890.00% |
| Cost of Revenue | 944.00% | -- | -- | -- | -- |
| Gross Profit | -7.66% | 413.95% | 243.40% | 342.42% | 2,640.00% |
| SG&A Expenses | 8.27% | 0.61% | -2.30% | -35.09% | 71.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.71% | 18.36% | 7.61% | -33.92% | 52.32% |
| Operating Income | -20.81% | 2.66% | 6.25% | 42.50% | -29.79% |
| Income Before Tax | -8.47% | 84.50% | 34.47% | 38.47% | -44.70% |
| Income Tax Expenses | -- | -- | -50.00% | -- | -- |
| Earnings from Continuing Operations | -8.24% | 84.50% | 34.48% | 38.47% | -45.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.24% | 84.50% | 34.48% | 38.47% | -45.02% |
| EBIT | -20.81% | 2.66% | 6.25% | 42.50% | -29.79% |
| EBITDA | -21.12% | 3.96% | 7.35% | 43.39% | -26.57% |
| EPS Basic | 33.38% | 92.59% | 54.06% | 67.72% | 40.53% |
| Normalized Basic EPS | 33.15% | 89.38% | 47.68% | 70.21% | 40.70% |
| EPS Diluted | 33.38% | 92.59% | 54.06% | 67.72% | 40.53% |
| Normalized Diluted EPS | 33.15% | 89.38% | 47.68% | 70.21% | 40.70% |
| Average Basic Shares Outstanding | 62.44% | 62.98% | 56.40% | 90.62% | 143.88% |
| Average Diluted Shares Outstanding | 62.44% | 62.98% | 56.40% | 90.62% | 143.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |